Nazareth, Israel-based NGT3 is an early-stage investment firm that focuses on the life sciences, medical devices and pharmaceutical companies working on next-generation technologies. The firm began two decades ago as an incubator and floated its first venture capital fund in 2013. It is now doing the groundwork for the second […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.